Vitamin K-dependent protein production in transgenic animals.

Abstract:

:Vitamin K-dependent proteins are currently purified from pooled human plasma or produced in mammalian cell culture systems by recombinant DNA technology. Transgenic animals may provide an additional expression system for the production of these therapeutic proteins. Mice have been used to test hybrid genes which direct the expression of recombinant factor IX and Protein C to the mammary gland. Transgenic livestock have also been created that secrete into milk fully active Protein C at 0.3 mg/mL, and factor IX at 0.2 mg/mL. Thus, it is feasible to develop genetically manipulated livestock for the industrial production of vitamin K-dependent proteins.

journal_name

Thromb Haemost

authors

Luboń H,Paleyanda RK

subject

Has Abstract

pub_date

1997-07-01 00:00:00

pages

532-6

issue

1

eissn

0340-6245

issn

2567-689X

journal_volume

78

pub_type

杂志文章,评审
  • A mutation in the protein S pseudogene is linked to protein S deficiency in a thrombophilic family.

    abstract::Probands from 15 unrelated families with hereditary protein S deficiency type I, that is having a plasma total protein S concentration fifty percent of normal, were screened for abnormalities in their protein S genes by Southern analysis. Two probands were found to have a deviating DNA pattern with the restriction enz...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Ploos van Amstel HK,Reitsma PH,Hamulyák K,de Die-Smulders CE,Mannucci PM,Bertina RM

    更新日期:1989-11-24 00:00:00

  • Review on the value of graduated elastic compression stockings after deep vein thrombosis.

    abstract::Graduated elastic compression stockings (GECS) are commonly used in the primary prevention of deep vein thrombosis (DVT); however, their role in preventing recurrent DVT and also post-thrombotic syndrome is less well established. The aim of this review was to investigate the effect of GECS after DVT. A literature sear...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Kakkos SK,Daskalopoulou SS,Daskalopoulos ME,Nicolaides AN,Geroulakos G

    更新日期:2006-10-01 00:00:00

  • Age at first treatment and immune tolerance to factor VIII in severe hemophilia.

    abstract::Findings from a recent study suggest that earlier start of treatment with factor VIII in patients with severe hemophilia is associated with a higher risk to develop inhibitors. We set out to assess the association between age of first administration of clotting factor VIII and the risk to develop inhibitors in infants...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: van der Bom JG,Mauser-Bunschoten EP,Fischer K,van den Berg HM

    更新日期:2003-03-01 00:00:00

  • Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.

    abstract::Direct oral factor inhibitors (DOFIs) are an attractive alternative to vitamin K antagonists (VKA) for the treatment of patients with antiphospholipid syndrome (APS). In the absence of prospective, randomised trial data, reports of therapeutic failures in clinical practice alert clinicians to potential limitations of ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH14-03-0272

    authors: Schaefer JK,McBane RD,Black DF,Williams LN,Moder KG,Wysokinski WE

    更新日期:2014-11-01 00:00:00

  • Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.

    abstract::The fibrin-specificity and procoagulant effects of recombinant staphylokinase (Sak42D) were compared with those of recombinant tissue-type plasminogen activator (rt-PA) in patients with acute myocardial infarction. Plasma samples were obtained at baseline and at 25 and 90 min, from 24 patients who were randomly assign...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Okada K,Lijnen HR,Moreau H,Vanderschueren S,Collen D

    更新日期:1996-12-01 00:00:00

  • Baboon models of acute arterial thrombosis.

    abstract::In conclusion, we believe that the baboon offers many advantages as an experimental animal to study vascular disease, thrombus formation and dissolution, the effects of mediating variables, and the relative efficacy of therapeutic interventions. Each specific application for testing therapeutic agents may require test...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Hanson SR,Harker LA

    更新日期:1987-10-28 00:00:00

  • Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro.

    abstract::Tridegin is a potent inhibitor of factor XIIIa from the leech, Haementeria ghilianii, which inhibits protein cross-linking. It modifies plasmin-mediated fibrin degradation as shown by the absence of D-dimer and approximately halves the time for fibrinolysis. Plasma clots formed in the presence of Tridegin lyse more ra...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Seale L,Finney S,Sawyer RT,Wallis RB

    更新日期:1997-05-01 00:00:00

  • Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.

    abstract::Global coagulation assays display variable effects at different concentrations of rivaroxaban. The aim of this study is to quantify the ex vivo effects of low-dose rivaroxaban on thrombophilia screening assays and coagulation factor activities based on the administration time, and to show how to mask possible inter...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH12-04-0228

    authors: Mani H,Hesse C,Stratmann G,Lindhoff-Last E

    更新日期:2013-01-01 00:00:00

  • Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice.

    abstract::Recurrent joint bleeding is the most common manifestation of haemophilia resulting in haemophilic arthropathy (HA). The exact pathophysiology is unknown, but it is suggested that arthropathy is stimulated by liberation of fibrinolytic activators from the synovium during haemarthrosis. The aim of this study was to test...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH13-01-0080

    authors: Nieuwenhuizen L,Roosendaal G,Coeleveld K,Lubberts E,Biesma DH,Lafeber FP,Schutgens RE

    更新日期:2013-07-01 00:00:00

  • A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.

    abstract:BACKGROUND:Recombinant hirudin, a pure, specific antithrombin could be more effective than heparin in the treatment of deep vein thrombosis, but its short half-life requires constant intravenous infusion, whereas subcutaneous administration of recombinant hirudin can ensure stable and prolonged plasma levels. The aim o...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章

    doi:

    authors: Schiele F,Vuillemenot A,Kramarz P,Kieffer Y,Soria J,Soria C,Camez A,Mirshahi MC,Bassand JP

    更新日期:1994-05-01 00:00:00

  • European Concerted Action on Anticoagulation--comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors.

    abstract::A procedure for using citrated fresh plasmas for International Sensitivity Index (ISI) calibration of two types of whole blood point-of-care test (POCT) prothrombin time (PT) monitor systems has been assessed in a multicentre study. The CoaguChek Mini and TAS PT-NC systems gave higher ISI with whole blood samples than...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Poller L,Keown M,Chauhan N,van den Besselaar AM,Tripodi A,Shiach C,Jespersen J,European Concerted Action on Anticoagulation Steering Group Members.

    更新日期:2002-05-01 00:00:00

  • Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.

    abstract::To evaluate the role of low-molecular weight heparin (LMWH) as an alternative to oral anticoagulants in the prevention of recurrent venous thromboembolism, we compared in a randomized trial conventional warfarin treatment with a three-month course of enoxaparin 4000 anti-Xa units once a day subcutaneously. 187 patient...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Pini M,Aiello S,Manotti C,Pattacini C,Quintavalla R,Poli T,Tagliaferri A,Dettori AG

    更新日期:1994-08-01 00:00:00

  • Kinetics of In-111-platelets in the baboon: I. Isolation and labelling of a viable and representative platelet population.

    abstract::A fully representative and viable platelet population was isolated from the blood of 15 baboons by a multiwash procedure, and labelled with In-111-oxine. The recovery of the total platelet population in the circulation was 85% +/- 9. Mean platelet life span was 146 hr +/- 13. Correcting for plasma radioactivity (alway...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Kotzé HF,Lötter MG,Badenhorst PN,Heyns AD

    更新日期:1985-06-24 00:00:00

  • Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.

    abstract::This study compares the ability of unmodified and carbohydrate-modified forms of factor VIII/von Willebrand factor (FVIII/vWF) protein to bind to platelets in the presence of ristocetin or thrombin. Treatment of intact FVIII/vWF with alpha-D-neuraminidase results in more than 95% desialylation. Asialo FVIII/vWF retain...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Goudemand J,Mazurier C,Samor B,Bouquelet S,Montreuil J,Goudemand M

    更新日期:1985-06-24 00:00:00

  • Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.

    abstract::The haemostatic system and the use of heparin during cardiopulmonary bypass (CPB) have been studied extensively in adults but not in children. Results from adult trials cannot be extrapolated to children because of age-dependent physiologic differences in haemostasis. We studied 22 consecutive paediatric patients who ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Chan AK,Leaker M,Burrows FA,Williams WG,Gruenwald CE,Whyte L,Adams M,Brooker LA,Adams H,Mitchell L,Andrew M

    更新日期:1997-02-01 00:00:00

  • Uncertain thrombophilia markers.

    abstract::The development of venous thromboembolism (VTE), which includes deep-vein thrombosis and pulmonary embolism, may be associated with inherited or acquired risk factors that can be measured in plasma or DNA testing. The main inherited thrombophilias include the plasma deficiencies of the natural anticoagulants antithrom...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH15-06-0478

    authors: Franchini M,Martinelli I,Mannucci PM

    更新日期:2016-01-01 00:00:00

  • Heparan sulfate-protein interactions--a concept for drug design?

    abstract::The glycosaminoglycan, heparan sulfate (HS) is composed of alternating units of hexuronic acid and glucosamine, that are variously sulfate-substituted at different positions. Proteoglycans carrying HS chains are ubiquitously expressed at cell surfaces and in the extracellular matrix. The structures of these chains are...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Lindahl U

    更新日期:2007-07-01 00:00:00

  • Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting.

    abstract::Today, direct oral anticoagulants (DOAC) are widely used alternatives to Vitamin-K antagonists (VKA). Women of reproductive age may become pregnant during anticoagulation and, while VKA carry an embryotoxic potential, the risk of DOAC embryopathy is unknown. As a result, some patients elect to terminate pregnancy for ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH16-04-0305

    authors: Beyer-Westendorf J,Michalski F,Tittl L,Middeldorp S,Cohen H,Abdul Kadir R,Arachchillage DJ,Arya R,Ay C,Marten S

    更新日期:2016-09-27 00:00:00

  • Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.

    abstract::Antithrombotic potency of recombinant hirudins rHV2, rHV2-Lys47 and rHV2-Arg47 was studied in a model of experimental thrombosis induced by tissue factor in the rat. Venous thrombosis was induced by i.v. injection of 25 mg/kg tissue factor followed by stasis of the inferior vena cava. In this model natural recombinant...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Freund M,Cazenave JP,Courtney M,Degryse E,Roitsch C,Bernat A,Delebassée D,Defreyn G,Maffrand JP

    更新日期:1990-04-12 00:00:00

  • The impact of selectins on mortality in stable carotid atherosclerosis.

    abstract::Cellular adhesion molecules also known as selectins promote recruitment of inflammatory cells into the arterial wall where they interact with lipid particles leading subsequently to plaque formation. The intercellular adhesion molecule-1 (ICAM-1), the vascular cell adhesion molecule-1 (VCAM-1) and the endothelial-leuk...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH14-12-1014

    authors: Hoke M,Winter MP,Wagner O,Exner M,Schillinger M,Arnold Z,Mlekusch W,Maurer G,Koppensteiner R,Minar E,Goliasch G

    更新日期:2015-08-31 00:00:00

  • Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.

    abstract::Bypassing inhibitors in haemophilia patients is limited to activated (a) Factor(F)VII products. We introduced "FVa activity augmentation" as another bypassing strategy and studied effects of an engineered FVa variant designated superFVa. Procoagulant and clot stabilising properties of superFVa and recombinant human (r...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH15-07-0525

    authors: Bhat V,von Drygalski A,Gale AJ,Griffin JH,Mosnier LO

    更新日期:2016-03-01 00:00:00

  • Fibrin clot properties and their modulation in thrombotic disorders.

    abstract::Accumulating evidence indicates that accelerated formation of fibrin clots composed of compact, highly-branched networks with thin fibres which are relatively resistant to plasmin-mediated lysis can be commonly observed in patients with venous or arterial thrombosis. This review discusses characteristics of fibrin clo...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH14-01-0032

    authors: Undas A

    更新日期:2014-07-03 00:00:00

  • Characterization of an in vitro model to study the permeability of human arterial endothelial cell monolayers.

    abstract::A model has been developed to study the transport of fluid and macromolecules through human arterial umbilical cord endothelial cell monolayers in vitro. Cells were cultured on fibronectin-coated polycarbonate filters and formed within a few days a tight monolayer, with an electrical resistance of 17 +/- 4 Ohm.cm2. Th...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Langeler EG,van Hinsbergh VW

    更新日期:1988-10-31 00:00:00

  • Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.

    abstract::Sequential treatment of arterial occlusions of the leg with porcine plasmin and low dose streptokinase results in a strong systemic proteolysis as already seen in deep leg vein thrombosis. In 31 of 45 patients the blood flow through major arterial segments could be restored. Thrombolytic success is possible within the...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Marbet GA,Eichlisberger R,Duckert F,da Silva MA,Biland L,Widmer LK,Ritz R,Schmitt HE

    更新日期:1982-10-29 00:00:00

  • Role of the A+ helix in heparin binding to protein C inhibitor.

    abstract::Interactions between proteins and heparin(-like) structures involve electrostatic forces and structural features. Based on charge distributions in the linear sequence of protein C inhibitor (PCI), two positively charged regions of PCI were proposed as possible candidates for this interaction. The first region, the A+ ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Elisen MG,Maseland MH,Church FC,Bouma BN,Meijers JC

    更新日期:1996-05-01 00:00:00

  • The fibrinolytic potential of the normal primate following the generation of thrombin in vivo.

    abstract::Parameters of the fibrinolytic system were studied in a primate model where the generation of thrombin was promoted in vivo. The procoagulant stimulus used was a combination of human factor Xa in combination with phosphatidylcholine/phosphatidylserine lipid vesicles (PCPS) as the source of coagulant active phospholipi...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Giles AR,Nesheim ME,Herring SW,Hoogendoorn H,Stump DC,Heldebrant CM

    更新日期:1990-06-28 00:00:00

  • Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.

    abstract::It has been experimentally shown that endotoxin induces a significant increase in the blood levels of a plasminogen activator inhibitor (PAI). We evaluated the effect of different doses of heparin (5 to 20 IU kg-1 h-1), antithrombin III (10 to 40 U kg-1 h-1 and 240 U/kg as bolus) and of a combination of the two on: 1)...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Gómez C,Páramo JA,Colucci M,Rocha E

    更新日期:1989-09-29 00:00:00

  • A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen.

    abstract::A new method to determine the concentration of free protein S in plasma is described. It is an enzyme-linked ligandsorbent assay (ELSA) which utilises the protein S binding capacity of the natural ligand C4b-binding protein (C4BP) to capture the free protein S from plasma samples. The use of C4BP as ligand in the assa...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Giri TK,Hillarp A,Härdig Y,Zöller B,Dahlbäck B

    更新日期:1998-04-01 00:00:00

  • On the existence of platelet receptors for factor V(a) and factor VIII(a).

    abstract::The surface of the platelet expresses procoagulant phospholipids that bind coagulation factors and contribute to the procoagulant activity of the cell. The evidence, however, also suggests that platelets may possess specific receptors for coagulation Factors V(a) and VIII(a). Examination of a limited set of the availa...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Nesheim ME,Furmaniak-Kazmierczak E,Henin C,Côté G

    更新日期:1993-07-01 00:00:00

  • Inhibitor to factor VIII in mild haemophilia.

    abstract::Factor VIII inhibitors in mild haemophilia are uncommon and the management of such patients is controversial. The development of a persistently high responding F VIII inhibitor in a mild haemophiliac is reported and the behaviour of the inhibitor discussed in the context of the various therapeutic regimes employed for...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Kesteven PJ,Holland LJ,Lawrie AS,Savidge GF

    更新日期:1984-08-31 00:00:00